Immobility

doi:10.1017/9781316443217.011

11 - Immobility

from Section 2 - Targeting Effects

Published online by Cambridge University Press: 03 December 2019

Klaus T. Olkkola and

Douglas J. Eleveld

Edited by

Pedro L. Gambús and

Jan F. A. Hendrickx

Show author details

Pedro L. Gambús: Affiliation:
Hospital Clinic de Barcelona, Spain
Jan F. A. Hendrickx: Affiliation:
Aalst General Hospital, Belgium

Book contents

Get access

Summary

Surgical anaesthesia usually requires hypnosis, antinociception (ensuring blood pressure and heart rate control) and immobility with varying degrees of muscle relaxation. However, the relative contribution of these three components to the state of anaesthesia may vary between different anaesthesias and surgical procedures. While volatile anaesthetics may be used to produce anaesthesia in and by themselves, most often anaesthesia is produced by a combination of drugs. Anaesthesia produced by the concomitant use of hypnotics, analgesics and neuromuscular blocking drugs is called ‘balanced anaesthesia’.

Type: Chapter
Information: Personalized Anaesthesia
Targeting Physiological Systems for Optimal Effect
, pp. 157 - 174

DOI: https://doi.org/10.1017/9781316443217.011 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2020

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Tammisto, T, Olkkola, KT: Dependence of the adequacy of muscle relaxation on the degree of neuromuscular block and depth of enflurane anesthesia during abdominal surgery. Anesth.Analg. 1995; 80: 543–7.Google Scholar

Hibbs, RE, Zambon, AC: Agents acting at the neuromuscular junction and autonomic ganglia. In: Brunton, LL, Chabner, BA, Knollmann, BC. eds. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics, 12th Edition. New York, NY: McGraw-Hill. http://accessmedicine.mhmedical.com/content.aspx?bookid=1613%26sectionid=102158134 [last accessed 15 June, 2019].Google Scholar

Bowman, WC, Prior, C, Marshall, IG: Presynaptic receptors in the neuromuscular junction. Ann.NY.Acad.Sci. 1990; 604: 69–81.Google Scholar

Hemmerling, TM, Donati, F: Neuromuscular blockade at the larynx, the diaphragm and the corrugator supercilii muscle: a review. Can.J.Anesth. 2003; 50: 779–94.Google Scholar

Viby‐Mogensen, J, Engbaek, J, Eriksson, LI, Gramstad, L, Jensen, E, Jensen, FS, Koscielniak‐Nielsen, Z, Skovgaard, LT, Østergaard, D: Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents. Acta.Anaesthesiol. Scand. 1996; 40: 59–74.Google Scholar

Fuchs‐Buder, T, Claudius, C, Skovgaard, LT, Eriksson, LI, Mirakhur, RK, Viby‐Mogensen, J: Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision. Acta.Anaesthesiol. Scand. 2007; 51: 789–808.CrossRef Google Scholar PubMed

Eleveld, DJ, Kopman, AF, Proost, JH, Wierda, JM: Model to describe the degree of twitch potentiation during neuromuscular monitoring. Brit.J.Anaesth. 2004; 92: 373–80.Google Scholar

El-Orbany, MI, Joseph, NJ, Salem, MR: The relationship of posttetanic count and train-of-four responses during recovery from intense cisatracurium-induced neuromuscular blockade. Anesth.Analg. 2003; 97: 80–4.Google Scholar PubMed

Viby-Mogensen, J, Jensen, NH, Engbaek, J, Ording, H, Skovgaard, LT, Chraemmer-Jorgensen, B: Tactile and visual evaluation of the response to train-of-four nerve stimulation. Anesthesiology. 1985; 63: 440–3.Google Scholar

Eikermann, M, Groeben, H, Husing, J, Peters, J. Predictive value of mechanomyography and accelerometry for pulmonary function in partially paralyzed volunteers. Acta.Anaesthesiol. Scand. 2004; 48: 365–70.Google Scholar

Capron, F, Alla, F, Hottier, C, Meistelman, C, Fuchs-Buder, T: Can acceleromyography detect low levels of residual paralysis? A probability approach to detect a mechanomyographic train-of-four ratio of 0.9. Anesthesiology. 2004; 100: 1119–24.Google Scholar

Viby-Mogensen, J, Engbaek, J, Eriksson, LI, Gramstad, L, Jensen, E, Jensen, FS, Koscielniak-Nielsen, Z, Skovgaard, LT, Ostergaard, D: Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents. Acta.Anaesthesiol. Scand. 1996; 40: 59–74.CrossRef Google Scholar PubMed

Rowaan, CJ, Vandenbrom, RH, Wierda, JM: The Relaxometer: a complete and comprehensive computer-controlled neuromuscular transmission measurement system developed for clinical research on muscle relaxants. J.Clin.Monit. 1993; 9: 38–44.Google Scholar

Weber, S, Muravchick, S: Monitoring technique affects measurement of recovery from succinylcholine. J.Clin.Monit. 1987; 3: 1–5.Google Scholar

Kopman, AF: The relationship of evoked electromyographic and mechanical responses following atracurium in humans. Anesthesiology. 1985; 63: 208–11.Google Scholar

Colquhoun, D, Dreyer, F, Sheridan, RE: The actions of tubocurarine at the frog neuromuscular junction. J.Physiol. 1979; 293: 247–84.CrossRef Google Scholar PubMed

Mertes, PM, Laxenaire, PM, Alla, F: Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999–2000. Anesthesiology. 2003; 99: 536–45.CrossRef Google Scholar PubMed

Atherton, DPL, Hunter, JM: Clinical pharmacokinetics of the newer neuromuscular blocking drugs. Clin.Pharmacokinet. 1999; 36: 169–89.Google Scholar

Schiere, S, Proost, JH, Roggeveld, J, Wierda, M: An interstitial compartment is necessary to link the pharmacokinetics and pharmacodynamics of mivacurium. Eur.J.Anaesthesiol. 2004; 21 (11): 882–91.Google Scholar

Jensen, FS, Viby-Mogensen, J: Plasma cholinesterase and abnormal reaction to succinylcholine: twenty years’ experience with the Danish Cholinesterase Research Unit. Acta.Anaesthesiol. Scand. 1995; 39: 150–6.Google Scholar

Andrews, JI, Kumar, N, van den Brom, RHG, Olkkola, KT, Roest, GJ, Wright, PMC: A large simple randomized trial of rocuronium versus succinylcholine in rapid sequence induction of anaesthesia along with propofol. Acta.Anaesthesiol. Scand. 1999; 43: 4–8.Google Scholar

Gueret, G, Rossignol, B, Kiss, G, Wargnier, JP, Miossec, A, Spielman, S, Arvieux, CC: Is muscle relaxant necessary for cardiac surgery? Anesth.Analg. 2004; 99: 1330–3.Google Scholar

Li, YL, Liu, YL, Xu, CM, Lv, XH, Wan, ZH: The effects of neuromuscular blockade on operating conditions during general anesthesia for spinal surgery. J.Neurosurg.Anesthesiol. 2014; 26: 45–9.Google Scholar

King, M, Sujirattanawimol, N, Danielson, DR, Hall, BA, Schroeder, DR, Warner, DO. Requirements for muscle relaxants during radical retropubic prostatectomy. Anesthesiology. 2000; 93: 1392–7.Google Scholar

Dubois, PE, Putz, L, Jamart, J, Marotta, ML, Gourdin, M, Donnez, O: Deep neuromuscular block improves surgical conditions during laparoscopic hysterectomy: a randomised controlled trial. Eur.J.Anaesthesiol. 2014; 31: 430–6.Google Scholar

Kopman, AF, Naguib, M: Laparoscopic surgery and muscle relaxants. Is deep block helpful? Anesth.Analg. 2015; 120: 51–8.Google Scholar PubMed

Staehr-Rye, AK, Rasmussen, LS, Rosenberg, J, Juul, P, Lindekaer, AL, Riber, C, Gätke, MR: Surgical space conditions during low-pressure laparoscopic cholecystectomy with deep versus moderate neuromuscular blockade: a randomized clinical study. Anesth.Analg. 2014; 119: 1084–92.Google Scholar

Torensma, B, Martini, CH, Boon, M, Olofsen, E, Veld, B, Liem, RS, Knook, MT, Swank, DJ, Dahan, A: Deep neuromuscular block improves surgical conditions during bariatric surgery and reduces postoperative pain: a randomized double blind controlled trial. PLoS.One. 2016; 11: e0167907.CrossRef Google Scholar PubMed

Madsen, MV, Staehr-Rye, AK, Gätke, MR, Claudius, C: Neuromuscular blockade for optimising surgical conditions during abdominal and gynaecological surgery: a systematic review. Acta.Anaesthesiol. Scand. 2015; 59: 1–16.CrossRef Google Scholar PubMed

Kopman, AF, Naguib, M: Laparoscopic surgery and muscle relaxants. Is deep block helpful? Anesth.Analg. 2015; 120: 51–8.Google Scholar

Kopman, AF, Naguib, M: Is deep neuromuscular block beneficial in laparoscopic surgery? No, probably not. Acta.Anaesthesiol. Scand. 2016; 60: 717–22.CrossRef Google Scholar PubMed

Madsen, MV, Staehr-Rye, AK, Claudius, C, Gatke, MR: Is deep neuromuscular blockade beneficial in laparoscopic surgery? Yes, probably. Acta.Anaesthesiol. Scand. 2016; 60: 710–16.Google Scholar

Aronson, JK: Meyler’s Side Effects of Drugs, 16th Edition. Amsterdam-Oxford: Elsevier, 2015.Google Scholar

Spacek, A, Neiger, FX, Krenn, CG, Hoerauf, K, Kress, HG: Rocuronium-induced neuromuscular block is affected by chronic carbamazepine therapy. Anesthesiology. 1999; 90: 109–12.Google Scholar

Koenig, MH, Edwards, LT: Cisatracurium-induced neuromuscular blockade in anticonvulsant treated neurosurgical patients. J.Neurosurg.Anesthesiol. 2000; 12: 314–18.Google Scholar

Richard, A, Girard, F, Girard, DC, Boudreault, D, Chouinard, P, Moumdjian, R et al: Cisatracurium-induced neuromuscular blockade is affected by chronic phenytoin or carbamazepine treatment in neurosurgical patients. Anesth.Analg. 2005; 100: 538–44.Google Scholar

Spacek, A, Neiger, FX, Spiss, CK, Kress, HG: Chronic carbamazepine therapy does not influence mivacurium-induced neuromuscular block. Br.J.Anaesth. 1996; 77: 500–2.Google Scholar

Hemmerling, TM, Schuettler, J, Schwilden, H: Desflurane reduces the effective therapeutic infusion rate (ETI) of cisatracurium more than isoflurane, sevoflurane, or propofol. Can.J.Anesth. 2001; 48: 532–7.Google Scholar

Caldwell, JE, Heier, T, Wright, PM, Lin, S, McCarthy, G, Szenohradszky, J, Sharma, ML, Hing, JP, Schroeder, M, Sessler, DI: Temperature-dependent pharmacokinetics and pharmacodynamics of vecuronium. Anesthesiology. 2000; 92: 84–93.Google Scholar

Beaufort, AM, Wierda, JM, Belopavlovic, M, Nederveen, PJ, Kleef, UW, Agoston, S: The influence of hypothermia (surface cooling) on the time-course of action and on the pharmacokinetics of rocuronium in humans. Eur.J.Anaesthesiol.Suppl. 1995; 11: 95–106.Google Scholar PubMed

Stenlake, JB, Hughes, R: In vitro degradation of atracurium in human plasma. Br.J.Anaesth. 1987; 59: 806–7.Google Scholar

Cammu, G, Coddens, J, Hendrickx, J, Deloof, T: Dose requirements of infusions of cisatracurium or rocuronium during hypothermic cardiopulmonary bypass. Br.J.Anaesth. 2000; 84: 587–90.CrossRef Google Scholar PubMed

Eriksson, LI, Viby-Mogensen, J, Lennmarken, C: The effect of peripheral hypothermia on vecuronium-induced neuromuscular block. Acta.Anaesthesiol. Scand. 1991; 35: 387–92.Google Scholar

Vermeyen, KM, Hoffmann, VL, Saldien, V: Target controlled infusion of rocuronium: analysis of effect data to select a pharmacokinetic model. Br.J.Anaesth. 2003; 90: 183–8.Google Scholar

Motamed, C, Devys, J-M, Debaene, B, Billard, V: Influence of real-time Bayesian forecasting of pharmacokinetic parameters on the precision of a rocuronium target-controlled infusion. Eur.J.Clin.Pharmacol. 2012; 68: 1025–31.CrossRef Google Scholar PubMed

Ma, X-D, Yan, J, Dai, B-Z, Kong, D-Q, Du, S-Y, Li, B-P: Comparative study: efficacy of closed-loop target controlled infusion of cisatracurium and other administration methods for spinal surgery of elderly patients. Eur.Rev.Med.Pharmacol.Sci. 2017; 21: 606–11.Google Scholar

Kansanaho, M, Olkkola, KT: Performance assessment of an adaptive model-based feedback controller: comparison between atracurium, mivacurium, rocuronium and vecuronium. Int.J.Clin.Monit.Comput. 1997; 13: 217–24.Google Scholar

Eleveld, DJ, Proost, JH, Wierda, JM: Evaluation of a closed-loop muscle relaxation control system. Anesth.Analg. 2005; 101: 758–64.Google Scholar

Eriksson, LI. Evidence-based practice and neuromuscular monitoring: it’s time for routine quantitative assessment. Anesthesiology. 2003; 98: 1037–9.Google Scholar

Vanacker, BF, Vermeyen, KM, Struys, MM, Rietbergen, H, Vandermeersch, E, Saldien, V, Kalmar, AF, Prins, ME: Reversal of rocuronium-induced neuromuscular block with the novel drug sugammadex is equally effective under maintenance anesthesia with propofol or sevoflurane. Anesth.Analg. 2007; 104: 563–8.Google Scholar

Ploeger, BA, Smeets, J, Strougo, A, Drenth, HJ, Ruigt, G, Houwing, N, Danhof, M. Pharmacokinetic-pharmacodynamic model for the reversal of neuromuscular blockade by sugammadex. Anesthesiology. 2009; 110 (1): 95–105Google Scholar

Kleijn, HJ, Zollinger, DP, van den Heuvel, MW, Kerbusch, T: Population pharmacokinetic–pharmacodynamic analysis for sugammadex‐mediated reversal of rocuronium‐induced neuromuscular blockade. Brit.J.Clin.Pharm. 2011; 72 (3): 415–33.Google Scholar

Proost, JH, Schiere, S, Eleveld, DJ, Wierda, JM: Simultaneous versus sequential pharmacokinetic‐pharmacodynamic population analysis using an iterative two‐stage Bayesian technique. Biopharm.Drug.Dispos. 2007; 28 (8): 455–73.Google Scholar

Schmith, VD, Fiedler-Kelly, J, Phillips, L, Grasela, TH: Prospective use of population pharmacokinetics/pharmacodynamics in the development of cisatracurium. Pharm.Res. 1997; 14 (1): 91–7.Google Scholar

Liu, J, Lu, C, Zou, Q, Wang, S, Peng, X: Altered pharmacodynamics and pharmacokinetics of cisatracurium in patients with severe mitral valve regurgitation during anaesthetic induction period. Brit.J.Clin.Pharm. 2017; 83 (2): 363–9.Google Scholar

Tran, TV, Fiset, P, Varin, F: Pharmacokinetics and pharmacodynamics of cisatracurium after a short infusion in patients under propofol anesthesia. Anesth.Analg. 1998; 87 (5): 1158–63.Google Scholar